Charges for counterfeit syringes in Austria

Process - Charges for counterfeit syringes in Austria

Two entrepreneurs are set to stand trial in Austria for alleged trading of falsified insulin pens. A spokeswoman of the Landgericht in the Austrian city of Steyr announced that the trial is scheduled to take place on September 16th. The "Oberösterreichischen Nachrichten" and "Kronen Zeitung" had previously reported on the indictments.

The prosecution accuses the two men of violations against the Medicinal Products Act as well as grossly negligent bodily harm in three cases. Austrian authorities reported several health endangering situations in the past October. The affected individuals had received counterfeit versions of the diabetes pen Ozempic.

The medication is also highly sought after as a diabetes treatment. The counterfeit pens contained insulin instead of the intended active ingredient Semaglutid, according to the Austrian Federal Office for Safety in Health Care (BASG).

The entrepreneurs allegedly sourced the counterfeits from abroad and sold them to a plastic surgeon in Salzburg, who then further distributed them. The investigations against the surgeon are not yet concluded.

1. Following the reports in "Oberösterreichischen Nachrichten" and "Kronen Zeitung", an indictment against two entrepreneurs for trading falsified Steyr-produced insulin pens was announced by the Landgericht in Austria, with the trial set to commence on September 16th.
2. The indictment includes accusations of violations against the Medicinal Products Act and grossly negligent bodily harm in three cases, stemming from the sale of these counterfeit insulin pens.
3. In addition to affecting diabetes patients, the health risks extended to individuals who received slimming syringes filled with insulin instead of the intended active ingredient, as reported by the Austrian Federal Office for Safety in Health Care (BASG).
4. Subsequent news reports highlighted the ongoing investigation into a plastic surgeon in Salzburg, who is suspected of buying and further distributing these falsified insulin pens during the process, potentially endangering the health of his patients.

Read also:

• Severe flooding continues in southern Germany.
• Floods continue to pose a major threat in southern Germany.
• Rising floods in the southern regions
• Floods: water levels remain critical in many places